The Covid-19 pandemic has catalyzed the adoption of telecommunications as a substitute for in-person encounters across many industries, including healthcare. Already a growing practice, telehealth services that remotely connect doctors and patients have surged in recent months, promising convenience, efficiency, and safety.
Questions remain, however, as to telehealth’s impacts on the long term cost and quality of care, the limitations of remote practice, and the adequacy of conventional healthcare policy to address this growing service. The pandemic has brought about ad hoc adjustments in payment systems and privacy regulations, but what changes might or should accompany a return to normalcy?
On July 8, please join the Manhattan Institute for a discussion with healthcare policy and industry experts about telehealth’s promises and challenges, and what implications this innovation has for public policy and medicine in the United States.